EUVIMEDEUVIMED entdecken
Open Access

The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo

Sei Morinaga, Ming Zhao, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hiroyuki Tsuchiya und 2 weitere

In Vivo · 2025

DOI: 10.21873/invivo.13807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Sei Morinaga und 13 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Chloroquine, Fibrosarcoma, Salmonella typhimurium, Autophagy. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChloroquineFibrosarcomaSalmonella typhimuriumAutophagyXenograft Model Antitumor AssaysAnimalsHumansMiceCell Line, TumorDrug SynergismMice, NudeDisease Models, AnimalApoptosis

Stichwörter der Autor:innen

Salmonella typhimurium A1-Rautophagy-inhibitorchloroquinecombinationfibrosarcomanude miceoral administrationsynergy HT1080tumor eradication

Substanzen

Chloroquine

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Morinaga, S., Zhao, M., Mizuta, K., Kang, B. M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2025). The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo. In Vivo. https://doi.org/10.21873/invivo.13807

Vancouver

Morinaga S, Zhao M, Mizuta K, Kang BM, Bouvet M, Yamamoto N, et al. The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo. In Vivo. 2025. doi:10.21873/invivo.13807

BibTeX
@article{Morinaga2025,
  author = {Morinaga, Sei and Zhao, Ming and Mizuta, Kohei and Kang, Byung Mo and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13807}
}
Kostenlos starten →